Tata Elxsi in partnership with DENSO Robotics Europe and AAtek, announced the inauguration of the ‘Robotics and Automation Innovation Lab’ at its Frankfurt office. This facility aims to drive the future of robotics automation across sectors such as medical devices, pharmaceuticals, life sciences and food science.
Equipped for both proof-of-concept (POC) and full-scale development, the lab will serve as a research and development hub, focusing on modular automation, accelerating product development, and simplifying maintenance to meet global demand for automation solutions. This includes live demonstrations of high-precision and modular robotic implementations in cell/tissue culture, diagnostics, and sterilised environments.
The new facility will leverage AI-driven analytics to support personalised medicine, automated handling of cell cultures in sterile environments, liquid handling and dispensing solutions, hospital lab automation, drug discovery, bioprocessing, and diagnostics. The centre will provide services including product design and engineering, application development, platform engineering, and regulatory compliance support.
The lab is also open to researchers and students from the Frankfurt Innovation Center (FIZ) and the startup ecosystem in the Hessen region.
The launch event was inaugurated by key leaders from all three companies, including Manjunath Kulkarni, VP, Client Relationship, Tata Elxsi; Arun Damodaran, Founder and CEO, AAtek Group; Dirk Schöffler, Head, DENSO Robotics Europe; and Bhupendra Singh Nikhurpa – Consul Commerce, Consulate General of India – Frankfurt.
With a roadmap for future expansion in USA and India, this lab aims to enable the global robotics and automation landscape.